Modulation of alloimmune response by commensal gut microbiota and potential new avenues to influence the outcome of allogeneic transplantation by modification of the 'gut culture'
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Host defence response against microbial infections was the foundation for the Science of Immunology. Now, we know the mechanisms of such host defence which include innate immune responses that is generally nonspecific but effective in many cases and lead to more specific responses called adaptive immune response. The gene loci of class I, II and III of the major histocompatibility complex (MHC) play a major role in directing the adaptive immune responses by presenting processed antigens to T and B cells to induce appropriate antigen-specific cellular and or humoral immune responses. In humans, these are commonly referred to as human leucocyte antigens class I/II-HLA I/II). The class III region, the gamma region in the MHC complex, is mostly associated with regulation of immune responses along with genes associated with complement activation. The adaptive immune responses are orchestrated by T and B cells that are tuned to respond to antigens that are normally foreign to the body, because these cells are educated to avoid selfantigens by a process of thymic education and selection of the T cells that are mostly non-self-reactive which also helps the B cells in eliciting specific immune responses to non-self-antigens. A by-product of this is the ability of the T and B cells to elicit strong immune responses to foreign HLA/MHC (alloimmune response), which developed into the field of histocompatibility testing for allogeneic transplantation of stem cells and organs. Now, we are beginning to learn that such alloimmune responses can be influenced by the microbiota that symbiotically live in our body especially on the mucosal surfaces and on the skin. This review deals with new and emerging data on how the commensal mucosal and skin microbiota influence the immune homeostasis, and how manipulating the commensal microbiota of the mucosa and skin could influence the survival and long-term functions of the allografts. Also, alterations of the microbiota by the inevitable immunosuppression prior to and following allogeneic transplantation could contribute towards the outcome of the allografts by alloimmune responses generated due to microbial antigen vs HLA cross-reactivity.
Introduction
Immunology began as an integral part of microbiology. All we knew at this inception of immunology was that there are antibodies that agglutinate, precipitate and activate complement when the antibodies bind to their cognate antigen on cell surfaces, or bacteria, and cause the lysis of cells/bacteria and also bind and neutralize toxins and viral infectivity. So at this time of the infancy of immunology, immune responses were associated with infections which still is true. But the field of immunology entered a new field when we learned that serum from some individuals could agglutinate white blood cells from some other individuals and the factors that caused this agglutination were immunoglobulins in the serum: this was the inception of the science of human histocompatibility antigens (HLA) and the beginning of the field of histocompatibility and immunogenetics. Subsequently, we learned about T cells, B cells, NK cells, macrophages and specific roles of T and B cells in microbial immunity. We then unravelled a broad genomic segment called major histocompatibility complex (MHC) which is synonymous with HLA in humans, the main purpose of which is elicitation of immune responses towards antigens that are non-self, how HLA/MHC processed antigens and how HLA/MHC influenced induction of immune responses and what guided these events. These happened in the 1970s after Zingernagel and Doherty discovered the MHC restriction phenomenon which led to the role of HLA/MHC in inducing specific adaptive immune responses against antigens derived from microbes, tumours, allografts and to autoantigens. The purpose of this broad review was to examine as to how this initial association of immunology and microbiology has come to a complete circle in terms of relationship between (i) the microbes and protective immune responses, (ii) influences of the commensal microbiota on immune homeostasis, and (iii) modulation of the alloimmune response by commensal microbiota, (iv) alloimmune responses generated by cross-reactivity between microbial and HLA antigens.
A very recent review by Rouse & Mueller (2016) alluded to this issue by their statement that 'microbes at mucosal surface sites can influence systemic immune responses to many antigens that include viral infections and vaccines' (Caballero & Pamer, 2015) . An indepth review on this topic, termed as 'transkingdom' metagenomics, is given by Pfeiffer & Virgin (2016) .
We expect our immune system to defend us against pathogenic microbes, to prevent the growth and expansion of tumour cells, to eliminate abnormal or dead cells or immune complexes -many of which are accomplished by our natural immune system. However, such defence may also require the immune responses specific to a specific antigenic component that can be recognized by T cells and B cells. T cells can only 'See' peptides presented by the MHC (HLA) and T cells then help the B cells to generate specific Bcell response (antibodies) towards specific antigens.
The intention of this review is to highlight as to how microbes at the mucosal surfaces can affect alloimmune responses which is directed against a mismatched transplantation.
Allogeneic transplantation
For end-stage organ diseases, the only cure is transplantation of the nonfunctional organ. And in primary hematopoietic disorders due to malignancies/or primary immunodeficiency disorders or secondary due to chemotherapy of malignant solid tumours resulting in a bone marrow failure, hematopoietic stem cell transplantation is the ultimate resort. In either situation, it is not always easy to get a donor that is compatible with the recipient due to differences in antigens expressed on the cell surfaces collectively called histocompatibility antigens (HLA). When the donor and the recipient are compatible, then the transplant is likely to survive for long time due to minimal immunological risks. However, most transplants, especially solid-organ transplantations, are carried out with grafts from HLA-mismatched donors based on pre-existing alloimmune status and based on the currently available immunosuppressive agents to reduce immunological injuries to the mismatched allograft to the minimum and also to avoid recurrent microbial diseases due to compromised immune system.
What is alloimmune response?
This is an immune response towards the antigens of a genetically nonidentical individual (alloantigen). And, the most prominent alloantigens are HLA/MHC. Alloimmune response towards HLA/MHC is not a desired function, but it is an unavoidable by-product of the education of immune system to distinguish self from non-self. There are two types of alloimmune responses: (i) direct alloimmune response: when the host's educated T cells recognize an HLA/MHC which is present on foreign cells and develop an immune response to get rid of those cells; (ii) indirect alloimmune response: when the host's educated T cells recognize a processed alloantigen presented by the host's cells in the context of the host's HLA/MHC and develop an immune response to get rid of any cells in the host expressing those recognized antigens.
Due to shortage of organs available from deceased donors, and constraints with willing living related and unrelated donors for medical and social reasons, most solid-organ transplants (SOT) are carried out with mismatched donor/recipient pairs.
The current ability to detect specific alloantibodies against the potential donor has developed an alloantibody-based matching for SOT. Basically, organs are transplanted even if they are not matched at HLA loci provided the recipient has no antibodies against the prospective donor's mismatched HLA antigens. While T-cell responses against the mismatched HLA are also of crucial importance, for practical purposes, antibodies are used as a yardstick of alloimmune status in the recipient.
The latest advancement in human genome-sequencing technologies namely next-generation sequencing (NGS) which has the ability to accurately type HLA alleles to almost perfection will have the potential to finer allele to allele matching for stem cell transplantations. In the case of SOT, NGS-based sequencing will pave the way to determine fine matching-based antibodies that are directed against specific alleles of an HLA antigen.
Lifelong immunosuppression
We know transplantation with mismatched HLA requires lifelong immunosuppressant treatment of the recipient to avoid or minimize alloimmune responses against the mismatched antigens. Also immunosuppression can cause blunting of normal immune defence of the recipient against many infectious agents and cause re-activation of dormant/latent viral infections. In many cases, antibiotic/antiviral immunoprophylaxis is essential to protect the recipient from life-threatening infections. These antibiotics treatment could tilt the commensal microbiota and that is where the new insights into the ability of utilizing the potential of microbiota to modulate alloimmune response come to play.
Healthy microbes
We knew the use of live microorganisms to maintain bowel health and prolong life as early as 1900s (June & Mazmanian, 2009 ). The term 'probiotics' is used to describe dietary microbes conferring healthy benefits. The common feature of almost all bacterial species used as probiotics is the ability of these organisms to control inflammation. Bacterial species can act on several cell types (epithelial cells, dendritic cells (DCs) and T cells. Recent evidence suggests that induction of regulatory T cells (T-Reg Cells) by these organisms is crucial to limiting inflammation and disease (Troy & Kasper, 2010) . A polysaccharide A (PSA) produced by the human symbiont Bacteroides fragilis was shown the cellular and physical development of the immune system, including expansion and differentiation of splenic CD4 + T cells. The novel immunomodulatory activities of PSA include correcting systemic T-cell deficiencies, T helper cell imbalances and directing lymphoid organogenesis. The importance of B. fragilis in maintenance of a healthy immune response was recently illustrated by the finding that colonization by Bacteriodes fragilis or treatment with purified PSA can protect from the induction of experimental inflammatory bowel disease (IBD). Oral treatment of mice with purified PSA protects recipients from weight loss, decreases levels of the pro-inflammatory cytokines TNFa, IL-17 and IL-23 and inhibits epithelial hyperplasia and neutrophil infiltration to the gut associated with disease induction in these models.
Molecular concepts that could help to understand the connection between microbes and alloimmune responses
There are some molecular concepts that we need to assimilate before we explore the potential use of good and healthy gut microbiota to modulate alloimmune response to prolong the survival of the allograft with reduced alloimmune response and decreased rate of debilitating or life-threatening infections. These are described below:
Pattern recognition receptors (PRR); damage-associated molecular patterns (DAMPs); pathogen-associated molecular patterns (PAMPs) -these molecules are unique to each pathogen.
Ironically, these PAMPS are essential molecular structures required for the survival of the pathogens.
The PAMPS (the microbe-specific molecules) that are recognized by a given PRR are as follows • N-Formylmethionine, lipoproteins and fungal glucans and chitin.
• DAMPs include -uric acid, extracellular ATP and many other compounds Many of these interactions may lead to stimulate or engage the cells involved in the innate immune system which in turn would help the initiation of the adaptive immune response.
Also, antigenic components from Klebsiella pneumonie, Shigella flexneri and Salmonella Yersinia, Campylobactor, proteus mirabiis, Klebsiella pneumonia have been found to cross-react with HLA antigens leading to alloimmune and autoimmune responses unrelated to the conventional way of alloimmunization, namely pregnancy, previous transplantation and transfusions.
HLA and immune response
While HLA is now almost synonymous with histocompatibility, the primary function of HLA is to present antigenic peptide fragments derived from invading microbes, toxins or other external antigenic assaults, altered self-antigens and cancer-specific antigens to the immune system to elicit appropriate adaptive humoral and cellular immune responses. The tremendous extent of HLA polymorphism is driven by the immune system's strategy to deal with ever emerging infectious and noninfectious antigenic assaults to the host. The newly emerging research of gut microbiota's influence on immune response connects this fundamental role of HLA to transplant immunology and histocompatibility assessment. Recent ASHI Annual meetings have highlighted the role of intestinal microbiota in alloimmune response and allograft transplantation. This literature review will focus on this issue and hopes to prompt further discussion within our ASHI community to unravel mechanisms of modulation of alloimmune responses and also to start exploring newer strategies to control the undesired alloimmune response following transplantation with the help of our 'gut culture'.
Gut-associated lymphoid tissue (GALT) is a powerful immune induction site. With newer molecular microbial detection technologies, more than 1000 types of bacteria totalling more than a trillion organisms have been found to exist in a normal gut. Microbes and the innate immune system are connected by microbial products and PRRs expressed by the immune and parenchymal cells. Innate immune responses drive the adaptive immune responses towards recognition of microbial and transplant antigens. Recent research suggests that commensal microbiota living symbiotically in the human gut contribute to maintaining balance in the innate immune status in health and disease. Unfortunately, due to antibiotic prophylactic treatment, immunosuppression and in certain cases pre-existing autoimmune disorders, allograft transplant patients are at a disadvantage in terms of acquiring pathogenic microbial infections/invasions in the gut, which could upset the balance of the commensal bacterial flora and pathogenic microbial flora. Such tilting of the balance could negate the beneficial effects of the 'good culture' with mixing or even replacement with a 'bad culture'. These kinds of changes could affect the innate and adaptive immune responses including alloimmune responses critical to allograft transplant recipients with respect to the outcome of the graft.
Potential ways by which the composition of the microbiota modulates allograft rejection Lei et al. (2016) suggested that in addition to histocompatibility factors that we know are important in allogenic transplantation, the role of environmental factors remains ill-defined. While intestine and skin that are infested with bacteria have relatively worse transplant outcome than with sterile allografts such as kidney and heart relatively better survival and longterm graft function. Influence of host and donor microbiota on skin transplant rejection was demonstrated by Lei et al. (2016) . Based on a murine model these authors showed that pretreatment of donors and recipients with broad-spectrum antibiotics or use of germ-free (GF) donors and recipients resulted in prolonged survival of minor antigen-mismatched skin allograft. Interestingly, increased graft survival was associated with decreased type I IFN signalling in antigen-presenting cells (APCs) and reduced priming of alloreactive T cells. Additionally, GF mice were colonized with faecal material from untreated conventional mice increasing the ability of APCs to prime alloreactive T cells resulting in accelerated graft rejection suggesting that alloimmunity is modulated by the microbiota. And the conventional mice were treated with antibiotics prior to transplant resulting in delayed rejection of MHC-mismatched skin and MHC class IImismatched cardiac allografts.
The gut microbial status after transplantation and its relationship to complications following allograft transplantation Wang et al. (2015) have already published an excellent review after reviewing 112 articles on the effects of mucosal microbiota on alloimmune responses on liver, small intestine, kidney and hematopoietic stem cell transplantations and concluded that changes in gut microbial flora are associated with alloimmune responses, graft function and immunological rejections. What Wang et al. (2015) emphasize that significant dysbiosis of the gut microbial flora could lead to post-transplant infection, rejection, GVHD -all associated with modification of alloimmune responses. The authors also address potential intervention methods, such as administration of antibiotics, probiotics and prebiotics, to ameliorate these complications. And Wang et al. (2015) are optimistic that a thorough understanding of the mechanisms of the interactions of gut microbiota and alloimmune responses could make gut microbiota a therapeutic target in the future.
Altering intestinal microbial flora could benefit BMT Patients Jenq et al.(2012) studied graft-versus-host disease (GVHD) in murine and human recipients of allogeneic bone marrow transplantation (BMT) and opined that inflammation of the intestine is secondary to GVHD and is associated with major shifts in the composition of the intestinal microbiota. In mouse models of GVHD, inflammation was associated with loss of overall diversity and expansion of Lactobacillales and loss of Clostridiales. These authors found that eliminating Lactobacillales from the flora of mice before BMT increased the severity of GVHD, while reintroducing the predominant species of Lactobacillus mediated enhanced protection against GVHD. To correlate this with human allograft transplants, the authors observed that the gut flora of patients at the inception of intestinal inflammation caused by GVHD had patterns almost identical to those in mice. The authors also observed increased microbial chaos early after allogeneic BMT as a potential risk factor for subsequent GVHD. This microbial chaos could have been due to the conditioning regimen which could blunt the normal immune response resulting in potential profile changes of the microbial flora and or due to antibiotic prophylaxis. These authors suggest that gut flora regulation may reduce intestinal inflammation and improve outcomes for allogeneic BMT recipients.
Specific issue of Clostridium difficile in SOT
Clostridium difficile infection (CDI) of SOT recipients is higher than that seen in the general hospitalized population; SOT recipients are at higher risk for CDI because of frequent antimicrobial use, immune dysregulation and underlying comorbidities. It is documented that CDI is most common in the first 3 months after SOT due which could be due to high levels of immunosuppression associated with a mismatched transplant that could also potentially have pre-existing donor-specific HLA antibodies. Antibiotic use is an important risk factor in SOT due to the need for antimicrobial prophylaxis.
Interestingly, studies by Friedman-Moraco et al. (2014) have shown that a nonhistocompatibility-based allogenic transplantation, namely faecal microbiota transplantation, can be effective to treat refractory Clostridium difficile colitis in SOT recipients. These authors evaluates the potential benefit of faecal microbial transplantation (FMT) in allogenic transplant patients with refractory CDI and described two SOT recipients, one lung and one renal, both of whom had good resolution of their diarrhoea caused by C. difficile following two FMTs suggesting that sequential FMT may be beneficial to achieve a cure in these patients having a damaged microbiota due to antibiotic use and immunosuppression, both of which are necessary to maintain an allograft without immunological injuries and deleterious infections.
In another alloimmune-related scenario, Oh et al. (2012) showed that acute rejection of intestinal transplants was associated with reduced levels of formicates and an increased proportion of Proteobacteria, in the gut. This study was based on pyrosequencing of 16S ribosomal RNA gene tags to compare the composition of the ileal microbiota present during nonrejection, prerejection and active rejection states in small bowel transplant patients. Interestingly, during documentations of rejection, 'the proportions of phylum Firmicutes (P < 0.001) and the order Lactobacillales (P < 0.01) were significantly decreased, while those of the phylum Proteobacteria, especially the family Enterobacteriaceae, were significantly increased (P < 0.005'). These authors state that based on receiver operating characteristic analysis, relative proportions of several bacterial species in ileal effluents and especially Firmicutes could be used to discriminate between lack of rejection and active rejection. These authors suggest that small bowel transplant rejection is associated with changes in the microbial populations in ileal effluents and support microbiota profiling as a potential diagnostic biomarker of rejection. Future studies should focus to investigate whether the dysbiosis could affect the alloimmune responses to evaluate its role in allograft rejection/survival/failure.
Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome
It is known that bronchiolitis obliterans syndrome (BOS) interferes with long-term survival of lung allografts, and now, there are emerging evidences to link it to microbial infections. Willner et al. (2013) using 16s rRNA gene amplification compared the microbiota identified in bronchoalveolar lavage of the allograft Lung Bacterial 'Community profile "using the weighted Unifrac metric. And the relationship between microbial populations, BOS and other covariates was explored using PERMANOVA and logistic regression" and the "Microbiota" in transplant patients fell into two main groups: -those dominated by Pseudomonas or by Streptococcus and Veillonella'. The reestablishment of Pseudomonas aeruginosa in individuals with cystic fibrosis was negatively correlated with BOS. Interestingly, these authors also reported that that P. aeuroginosa in the microbiota protected against colonization by Aspergillus fumigatus, which was reported to be associated with development of BOS by Weigt et al. (2013) .
What are the potential mechanistic explanations based on the mostly observational studies? Alegre et al. (2014) has alluded to the potential mechanistic views on the effect of microbial commensals on alloimmunity. It appears that infections occurring prior to transplant can result in several TCRs that can cross-react with viral peptides/self-MHC and donor self-peptides/alloMHC. This means that pretransplant infections may have the potential to generate memory T cells that can bind to both viral antigens and alloantigens 'seen' on the transplanted organ. Based on previous murine studies, the presence of such crossreacting memory T cells is very significant because it could be difficult to suppress these cross-reactive memory T cells; we have the same problem with plasma cells as well, unless we use some of the trial drugs that are extremely expensive at this point. Infections contracted after transplantation can influence ongoing alloimmunity by influencing both na€ ıve and memory alloreactive T cells independently of TCR cross-reactivity. This occurs through activation of PRR (expressed on many cell types including donor and recipient hematopoietic, endothelial and epithelial cells) by microbial molecules, resulting in production of inflammatory cytokines. Thus, it is possible that the phenotype of a differentiating alloreactive T cell can mimic that of the antimicrobial ones, promoting Th1 differentiation. If the microbial infections occur posttransplant, theoretically, these effector T cells can have distinct adverse effects on allografts, through the cytokines and chemokines released by each T-cell phenotypes. These cytokine/chemokine storms can activate macrophages, neutrophils or eosinophils -cell populations whose importance is now better recognized in allograft immunopathology. Another issue addressed by these authors is the effect of vaccinations given routinely prior to or after allograft transplantation and based on the current literature. Potential scenarios include polyclonal B-cell activation with enhanced alloimmune response; however, more studies are required to clarify the pros and cons of vaccinations carried out in the context of allograft transplantation.
The conundrum of mucosal floral effects on organs that are associated with mucosa and that are not associated with mucosal flora There is a seminal point to be considered regarding the mucosal microbiota and their influence on allograft transplant and alloimmune responses. And this area needs to be investigated in detail further. Lung and intestine are closely associated with mucosal microbiota, while heart and kidney and liver are not. So, it is possible that the influence of the gut microbial system on lung/intestine is likely to be more of a direct effect on the alloimmune system pertaining to those allografts. On the other hand, kidney and heart are far away from the mucosal system and the influence on them could be more by indirect effect -namely induction of regulatory T cells, cytokines, chemokines.
So, we have good cultures and bad cultures -but we need to find the balance or tilt the balance towards heath in general and towards the better functioning and survival of the allografts.
So can we complete the circle where immunology began as an integral part of microbiology?
It is possible that the phenotype of a differentiating alloreactive T cell can mimic that of the antimicrobial ones, promoting Th1 differentiation. If the microbial infections occur post-transplant, theoretically, these effector T cells can have distinct adverse effects on allografts, through the cytokines and chemokines released by each T-cell phenotypes. These cytokine/ chemokine storms can activate macrophages, neutrophils or eosinophils -cell populations whose importance is now better recognized in allograft immunopathology. Vaccinations given routinely prior to or after allograft transplantation and based on the current literature could be potential scenarios which include polyclonal B-cell activation with enhanced alloimmune response. However more studies are required to clarify the pros and cons of vaccinations carried out in the context of allograft transplantation.
Conclusions
Based on the limited studies reported so far, the imbalance in the intestinal and other mucosal microbiota can influence alloimmune T-cell response and B-cell immune responses. Inevitable immunosuppression and in many cases the need for prophylactic and therapeutic antibiotic and antiviral treatments of transplanted patients could cause dysbiosis in the gut and other mucosal surfaces and skin. This dysbiosis could alter alloimmune responses as the limited studies show. This is the beginning of understanding of 'the culture we have' and how the changes in 'culture' could be utilized to affect the alloimmune responses in favour of successful survival of the allograft. We need indepth mechanistic studies where specialists are from disciplines of mucosal microbiology, transplant immunology, basic immunology and transplant surgeons/physicians. The optimism is that we might find more effective ways to manipulate the alloimmune response to enhance the survival of allografts by being able to alter the microbiota to ameliorate the adverse effects of alloimmune response in allograft transplantation.
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